|
Volumn 5, Issue 2, 2002, Pages 123-127
|
Microvessel density in prostate carcinoma
a a a a a a |
Author keywords
Microvessel density; Prostate cancer
|
Indexed keywords
CD34 ANTIGEN;
EOSIN;
HEMATOXYLIN;
MONOCLONAL ANTIBODY;
PARAFFIN;
DIAGNOSTIC AGENT;
ANGIOGENESIS;
ANTIGEN EXPRESSION;
ARTICLE;
BIOCHEMISTRY;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER RISK;
CANCER STAGING;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DATA ANALYSIS;
DENSITY;
DISEASE COURSE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MANTEL HAENSZEL TEST;
MICROVASCULATURE;
PATHOLOGY;
PREDICTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
SCORING SYSTEM;
TREATMENT OUTCOME;
BIOSYNTHESIS;
NEOVASCULARIZATION (PATHOLOGY);
PREDICTION AND FORECASTING;
PROSTATE TUMOR;
RISK FACTOR;
TUMOR RECURRENCE;
VASCULARIZATION;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD34;
DISEASE PROGRESSION;
FOLLOW-UP STUDIES;
HUMAN;
MALE;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEOVASCULARIZATION, PATHOLOGIC;
PREDICTIVE VALUE OF TESTS;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
RISK FACTORS;
SUPPORT, NON-U.S. GOV'T;
TREATMENT OUTCOME;
HUMANS;
|
EID: 0035996412
PISSN: 13657852
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.pcan.4500572 Document Type: Article |
Times cited : (127)
|
References (19)
|